Stay updated on Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedFooter shows Revision: v3.4.2, replacing the previous v3.4.1. This is a minor metadata update and does not affect the study information or page usability.SummaryDifference0.0%

- Check22 days agoChange DetectedNew revision tag 'Revision: v3.4.1' appears, replacing the previous 'Revision: v3.4.0'. This update does not change study details, eligibility criteria, or results displayed on the page.SummaryDifference0.0%

- Check29 days agoChange DetectedShow glossary feature added to the page and metadata now includes Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous capitalization variants and the older Revision: v3.3.4 were replaced.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4, with the page displaying Revision: v3.3.4.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded a Locations section including Ontario. Removed Ontario Locations and the HHS Vulnerability Disclosure (revision 3.3.2 to 3.3.3).SummaryDifference0.1%

- Check94 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study, and updated the revision to v3.3.2, replacing the previous PubMed-origin wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page.